Charles River Laboratories International plans to power its North American operations with renewable energy by 2023 through a long-term solar energy contract completed this week.The pharmaceutical company completed the 15-year VPPA with Duke Energy Sustainable Solutions for 102 MW of energy from the
Read More...
